dpp-4 inhibitor with glp-1 receptor agonist combination not recommended ada inhibitors and GLP-1RAs: cardiovascular safety and benefits 𝐋𝐚𝐭𝐞𝐬𝐭 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐨𝐟 𝐃𝐏𝐏-𝟒 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬

Back Lau, J, Bloch, K, Schffer, L, et al (24 Sept 2015) 'Discovery of the once-weekly glucagon-like peptide-1 (glp-1) analogue Semaglutide', Journal Medicinal Chemistry , 58/18

Blood pressure-related effects (low blood pressure, episodes of loss of consciousness), highlighting the need for careful monitoring

[DOI] [PubMed] [Google Scholar] 110

2 Although the number of glucose-lowering agents available to treat T2DM has increased dramatically over the past 10 years, gaps continue to exist in care and outcomes

You might develop various gastrointestinal side effects, including gas, bloating, indigestion, nausea, or irregular bowel movements

Bupropion has caused some people to have suicidal thoughts or actions or unusual changes in behavior, whether or not they are taking medicines used to treat depression